Filtered By:
Management: Uninsured
Therapy: Neoadjuvant Therapy
This page shows you your search results in order of date.
Order by Relevance | Date
Total 17 results found since Jan 2013.
Trends in and Prognostic Significance of Time to Treatment in Pancreatic Cancer: A Population-Based Study
CONCLUSIONS: Delayed treatment approaching 2 months was observed in 10% of the population. The rising temporal trend in TTT may be attributed to the increasing shift toward neoadjuvant CT/RT in early-stage PDAC and/or the increasing use of tissue biopsy prior to surgery.PMID:37624518 | DOI:10.1245/s10434-023-14221-9
Source: Ann Oncol - August 25, 2023 Category: Cancer & Oncology Authors: Kavin Sugumar Jonathan J Hue Shreya Gupta Mohamedraed Elshami Luke D Rothermel Lee M Ocuin John B Ammori Jeffrey M Hardacre Jordan M Winter Source Type: research
Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Nonmetastatic Pancreatic Adenocarcinoma
CONCLUSIONS: Despite survival benefits associated with adherence to operative standards and receipt of guideline-recommended therapy, compliance remains poor. Future efforts must be directed toward improved education and implementation efforts around both operative standards and therapy guidelines.PMID:37330447 | DOI:10.1245/s10434-023-13758-z
Source: Ann Oncol - June 17, 2023 Category: Cancer & Oncology Authors: Holly V Spitzer Phillip M Kemp Bohan Elizabeth L Carpenter Alexandra M Adams Shu-Ching Chang Gary Grunkemeier Timothy J Vreeland Ching-Wei D Tzeng Matthew H G Katz Daniel W Nelson Source Type: research
Understanding Factors Leading to Surgical Attrition for "Resectable" Gastric Cancer
CONCLUSION: Review of clinical trials shows attrition due to unavoidable tumor and treatment factors (~ 15%). The NCDB indicates non-medical patient and provider characteristics (i.e., age, insurance status, facility volume) associated with attrition. This combined analysis highlights specific opportunities for improving potentially curative surgery rates.PMID:37046129 | DOI:10.1245/s10434-023-13469-5
Source: Ann Oncol - April 12, 2023 Category: Cancer & Oncology Authors: Hanna H Kakish Fasih Ali Ahmed Evonne Pei Weichuan Dong Mohamedraed Elshami Lee M Ocuin Luke D Rothermel John B Ammori Richard S Hoehn Source Type: research
The Association of Race With Adequate Lymph Node Evaluation for Gastric Cancer
CONCLUSIONS: In the current study, non-White race, independent of socioeconomics, was significantly associated with adequate LN assessment. Future work is necessary to improve standardization and achieve higher rates of adequate LN assessment for all patients during resection for GC.PMID:35570820 | DOI:10.1177/00031348221101601
Source: The American Surgeon - May 16, 2022 Category: Surgery Authors: Miriam W Tsao Madison S Kahl Jeremiah L Deneve Danny Yakoub Evan S Glazer David Shibata Richa Jain Ian Clark Paxton V Dickson Source Type: research
Treatment disparities in muscle-invasive bladder cancer: Evidence from a large statewide cancer registry
CONCLUSIONS: Socioeconomic disadvantage and insurance status are patient-level factors associated with suboptimal treatment for muscle-invasive bladder cancer.PMID:35022140 | DOI:10.1016/j.urolonc.2021.12.004
Source: Urologic Oncology - January 13, 2022 Category: Urology & Nephrology Authors: Anup A Shah ZhaoJun Sun Kirsten Y Eom Valentina Grajales Kelly R Pekala Benjamin J Davies Bruce L Jacobs Lindsay M Sabik Source Type: research
Changes in Korean National Healthcare Insurance Policy and Breast Cancer Surgery Trend in Korea
CONCLUSION: IBR rate in patients undergoing TM increased after NHI reimbursement.PMID:34313035 | DOI:10.3346/jkms.2021.36.e194
Source: J Korean Med Sci - July 27, 2021 Category: General Medicine Authors: Musaed Rayzah Jai Min Ryu Jun Hee Lee Seok Jin Nam Seok Won Kim Se Kyung Lee Jonghan Yu Kyeong Tae Lee Sa Ik Bang Goo Hyun Mun Jai Kyong Pyon Byung Joon Jeon Jeong Eon Lee Source Type: research
